PF-8380

CAS No. 1144035-53-9

PF-8380 ( PF8380; PF-8380; PF 8380 )

Catalog No. M10512 CAS No. 1144035-53-9

Potent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 125 In Stock
50MG 205 In Stock
100MG 335 In Stock
200MG 494 In Stock
500MG 782 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-8380
  • Note
    Research use only, not for human use.
  • Brief Description
    Potent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood).
  • Description
    Potent autotaxin inhibitor (IC50= 2.8 nM in isolated enzyme assay; 101 nM in human whole blood). Modulates lysophosphatidic acid (LPA) levelsin vivoandin vitroby directly inhibiting autotaxin; reduces LPA levels both in plasma and at site of inflammation. Orally available.
  • Synonyms
    PF8380; PF-8380; PF 8380
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Autotaxin
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1144035-53-9
  • Formula Weight
    478.33
  • Molecular Formula
    C22H21Cl2N3O5
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 95 mg/mL (198.6 mM)
  • SMILES
    O=C(N1CCN(CCC(C2=CC=C3NC(OC3=C2)=O)=O)CC1)OCC4=CC(Cl)=CC(Cl)=C4
  • Chemical Name
    3,5-dichlorobenzyl 4-(3-oxo-3-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)propyl)piperazine-1-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gierse J, et al. J Pharmacol Exp Ther. 2010, 334(1):310-317.
molnova catalog
related products
  • CDP-840

    CDP-840 (CDP840;L-765527) is a potent and selective PDE4 inhibitor with IC50 of 4-45 nM for PDE 4 extracted from tissues or recombinant PDE 4 isoforms expressed in yeast.

  • Enpp-1-IN-14

    ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.

  • CHF6001

    A novel, highly potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 0.026 nM.